Multicyclic compounds and the use thereof
US7122679B2 · kind B2 · utility
6Cited by
6References
61Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2001 |
| Grant date | Oct 17, 2006 |
| Priority date | — |
| Expiry date | Jan 14, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.